Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / Season 2 / Episode 7: Dr. Roni Helene Grace Wright (UIC Barcelona)
Transcript
- 0:01Talk about a 2 for one special a simple blood test that can
- 0:04detect and perhaps help treat metastatic cancer.
- 0:09Well, isn't that interesting? A Barcelona molecular biologist
- 0:13helped create this, fueled by patient stories and your
- 0:17donations. Here's Martha Kaley, founder and
- 0:20executive directorofearlier.org. All right, everyone, I would
- 0:25like for you to meet Doctor Ronnie Wright.
- 0:27And she is just has got such exciting work and I'm so pleased
- 0:33that our medical Advisory Board can see the strength of the
- 0:38projects that we're funding. And I'll have her address that
- 0:41in a bit. But I wanted to introduce you.
- 0:43She's a PhD in molecular biology and science.
- 0:48Her work is focused on the basic discovery and translational
- 0:54oncology. And so she's been, she has
- 0:58identified or is working on identifying molecular
- 1:01vulnerabilities that are directly relevant to biomarker
- 1:05development and target treatment strategies.
- 1:09And I'm going to let her explain that a little bit.
- 1:12I have read this 14,000 times before.
- 1:16I learned about it. In my brain, but I think it is
- 1:20just very promising work and I hope, Ronnie, that you can share
- 1:24what you see in the future with it.
- 1:26So I'll just let you talk about the the strategy of this.
- 1:30Thank, Thank you, Martha. And, and just to say first thank
- 1:33you to earlier and to all the women behind the scenes that
- 1:37worked so hard to raise all these funds for supporting
- 1:41research all over the world. Really a fantastic job that you
- 1:45do. And I'm very, very pleased to be
- 1:47here today. Yeah, we're very excited about
- 1:50our our assay that was supported by earlier.
- 1:54So in our research lab, as you said, we work on basic research
- 2:00and also have more translational projects.
- 2:03And the translational projects supported by earlier really
- 2:07began about 10 years ago in 2016.
- 2:12Because I've always been fascinated about the
- 2:15particularly the process of how cancer cells from the primary
- 2:19tumor leave, migrate through the circulatory system and then
- 2:24metastasize in secondary sites. Because this process is is
- 2:30actually very difficult for for cancer cells to to do.
- 2:34You know, they have to undergo massive changes in their
- 2:37cellular makeup. They need to physically change
- 2:41their shape so they can squeeze between between cells and
- 2:45survive in quite a a hostile environment in the circulate
- 2:48circulatory system. So that process of metastases
- 2:54actually needs a huge amount of cellular energy to have to
- 2:58undergo all these all these changes.
- 3:00And in 2016, we identified a particular protein that was
- 3:07really elevated in metastatic cancer cells.
- 3:11And we showed that these cancer cells were increasing the levels
- 3:16of this protein so that they could increase the amount of
- 3:20energy that they physically had in allowing them to leave the
- 3:25primary site, survive in the circulation and then colonise in
- 3:30in secondary sites. So that was really the basic
- 3:33discovery that led to the development of the acid.
- 3:38If you Fast forward a couple of years, we developed a biomarker
- 3:42or an antibody to that particular protein that's only
- 3:46in metastatic cancer cells. And then we have used that
- 3:52antibody to create a prototype, which is the lateral flu assay.
- 3:57And it's something similar to COVID assay that unfortunately
- 4:02we're all kind of familiar with. So.
- 4:05It's something similar to that. It would be a very simple blood
- 4:09prick and we will be able to use that single drop of blood and
- 4:14see with the presence of a line like a COVID test whether there
- 4:18was metastatic cancer cells identified in those patients
- 4:24very quickly, noninvasive and relatively cheap to perform.
- 4:29And that would be the idea being that we could identify those
- 4:33circulating metastatic cells much earlier than other
- 4:38traditional methods and and scans.
- 4:41So would this be able to monitor or expand the understanding of
- 4:46the particular therapeutics that are being used?
- 4:49Would it be kind of an advice thing for OK, this one's not
- 4:53working, we do something else? Yeah.
- 4:56I, I think it's an, it's an interesting question because
- 4:59when we started out, we, our aim was for an earlier detection of
- 5:05metastasis test just for, for that, for monitoring.
- 5:09But since then we've also been able to develop a therapeutic
- 5:14against the particular target as well.
- 5:16So we have the combined diagnostic and therapeutic and
- 5:21exactly what you're saying, we believe that we could use this
- 5:25assay to help steer therapeutic options not and strategies for
- 5:31patients to really have a easy way to monitor the patients over
- 5:37time to see if they are responding well or not to
- 5:41particular therapies. Another thing we we thought
- 5:46about that maybe it would be beneficial was more than the
- 5:50psychological aspect of of it as well.
- 5:54You know that the stress and anxiety that is brought on and
- 5:59the women feel thinking about, you know, constantly worrying
- 6:03about whether it's come the tumor has come back, whether
- 6:06it's they have metastasis, whether it is spread.
- 6:09And we believe that perhaps this assay, because it is so easy to
- 6:14use and non evasive could maybe provide some some comfort and
- 6:20some reassurance also in between obviously regular programmed
- 6:25check UPS. So maybe it could help also with
- 6:27with that same things. So would it be useful in
- 6:32identifying the presence of breast cancer at an earlier at a
- 6:37very early state? Yeah.
- 6:41The the lateral flu assay would be able to to do that as well in
- 6:44a much earlier than than before. Also we can use the antibody
- 6:51that we developed the biomarker in patient tumors.
- 6:54We've already tested that in tissue, but it works in tissue
- 6:57as well as in the lateral flow assay as we've done here, so.
- 7:02It's possible. So what do you see as your next
- 7:05step? Well, we would like to take our
- 7:10prototype that we've developed to a much larger patient data
- 7:16set, you know, to really expand it much further.
- 7:20What we don't know at the moment, which is really the, the
- 7:25issue is exactly what is the limit.
- 7:28So what is the minimum number of metastatic cells in one drop
- 7:34that we can detect that sensitivity detection limit?
- 7:38We we don't know yet. So we're really just looking to
- 7:41try and secure additional funding to move it out into a
- 7:45much larger group using patient samples.
- 7:49Right. So in the long run, do you think
- 7:53that as you as you're able to use this, I'm going to I'm going
- 7:58to presume that we're going to get there with this, OK.
- 8:02So in the long run, so you think it would be they would test
- 8:07between visits to the doctor or that you could schedule like
- 8:13every three months to have a blood prick and then you would,
- 8:17you would know what was going on, right?
- 8:19Exactly that that's how we envision it and it's really just
- 8:23to it's not, it's not replacing anything.
- 8:26We're not, you know, stepping on anybody else's toes, so to
- 8:29speak. It's more just the more
- 8:31information that that we have the the better.
- 8:35So I think it's just a much more complimentary assay or test to
- 8:40go alongside what's already available and also to help like
- 8:44I was saying with the more the the anxiety and things with
- 8:48regards to recurrence especially.
- 8:51So you'll you'll need to get a bigger study, right?
- 8:56Yeah. You will shoot for that, but you
- 8:58have to. You're thinking you need to
- 9:01identify a little bit more about the the quantity that that would
- 9:07is necessary, correct? Exactly.
- 9:10To really know what is the limits, Yeah, what is the
- 9:15minimum limit that we can say is a threshold of this patient we
- 9:19can identify. And in other patients, perhaps
- 9:22if it's exceptionally low, we're not going to be able to see it
- 9:25at this stage, you know, because that information can help us
- 9:29moving forward to how can we make our assay even better, how
- 9:35can we get those patients that have really, really small
- 9:37amounts of, of sounds? And I think that's probably true
- 9:42for a lot of the research. Is the quantity the quantity
- 9:46that's necessary? For.
- 9:48Them identifying, I know like, like with extracellular vesicles
- 9:54and being available in blood as as compared to saliva, as
- 10:00compared to urine, it's a, it's much easier to find that in the
- 10:06blood rather than others. So I, I know that that's kind of
- 10:10one of those markers that you have to jump over to do great.
- 10:16So when do you when will you start trying to accumulate your
- 10:22great or larger scale? As as we move forward, just
- 10:26keeping looking for more funding to to support it.
- 10:29And then when we have that, we're we're ready to go.
- 10:32Well, well, you can always submit a, a grant proposal to
- 10:37our medical Advisory Board because they will certainly look
- 10:40at it and we have funded researchers a couple of
- 10:43different times because what the work is, what is so important to
- 10:47do. So I really thank you for that.
- 10:50Is there anything else you'd like to share or anything in
- 10:53your concepts about breast cancer and understanding of it?
- 10:57I think that I'm very excited about what the future holds for
- 11:01the research for for breast cancer.
- 11:04I see so many incredible ideas and discoveries and innovations
- 11:10every year. And I really believe that it's
- 11:13going to be a much more personalized treatment plan for
- 11:16each and every woman with breast cancer.
- 11:19I do think that's that's the way that it's going in in the
- 11:22clinics. And I just wanted to say as
- 11:25well, thank you. And I want to say something to
- 11:30the women out there that are struggling or have with with
- 11:34breast cancer in the past. And and that is that although we
- 11:39can't see us, you know, we're not in the clinics and we're not
- 11:43in the hospitals. Just to know that they're each
- 11:49and every one of their stories and their struggles that they
- 11:53share drives our passion and inspires us every day to get up
- 11:59and go to the lab and try to discover and innovate and really
- 12:05to let them know that, you know, you're not alone.
- 12:08We're all here all over the world, and we're fighting in the
- 12:11labs to try and support and develop better solutions for
- 12:16every woman that's suffering with breast cancer.
- 12:19That is fantastic. Thank you for sharing that.
- 12:22That's one of the reasons that I started doing this podcast is
- 12:27because I, as I have read the research and it seems like we
- 12:32are at such a wonderful point in time.
- 12:35I've been, I've been doing this for 30 years and the, the, the
- 12:40time frame is, is like it's exploding and it's got so much
- 12:44stronger and we're looking at it from so many different
- 12:47perspectives as compared to just one step in front of the other.
- 12:52So I think seeing it from so many angles and I people will
- 12:56say, well, are are they doing anything?
- 12:58I'm gonna go, yeah, let me tell you.
- 13:01So this is my way of saying here's here's what's going on.
- 13:05And to be able to meet researchers, I think is really
- 13:08so heart warming because just like you said, we're in it
- 13:11together and we're you all are motivating us to just keep keep
- 13:16raising funds and doing because we know that this is the path
- 13:19that's going to help us. So.
- 13:21And we're we're inspired by by you.
- 13:23Oh well, thank you so much and we appreciate your visit today
- 13:27and thank you and please stay in touch with us, OK.
- 13:32I will do all. Right.
- 13:33Thanks, Ronnie. Thank you.
- 13:34Bye. Thank you so much.
- 13:36Bye. This episode of Isn't That
- 13:39Interesting was made possible thanks to volunteers and donors
- 13:42just like you. It was hosted by Martha Kaley,
- 13:45founderofearlier.org and edited by Liam Mcburney.
- 13:49I'm Valerie Amsterdam, reminding you that for the last 30 years,
- 13:53this is North Carolina based organization has helped fund
- 13:56groundbreaking research all over the world, from molecular
- 14:00imaging to a sensitive blood test for breast cancer.
- 14:04Plain and simple, earlier detection saves lives.
- 14:07And you can help host a fundraising event, make a
- 14:10donation, or volunteer your time.
- 14:12You can find us not only on the web, but on Facebook and
- 14:15Instagram too. Let's change the picture of
- 14:18breast cancer together.